[IGF-1 levels in anterior cruciate ligament reconstruction using allograft vs autograft in patients at Central Military Hospital]. / Niveles de IGF-1 en la plastía de ligamento cruzado anterior de rodilla empleando aloinjerto vs autoinjerto en pacientes del Hospital Central Militar.

BACKGROUND: Treatment of ACL injury is surgical reconstruction. It is not known whether the result is better depending on the type of graft used. Insulin-like growth factor type 1(IGF-1) is a powerful stimulant of extracellular matrix and chondrocyte growth. MATERIAL AND METHODS: Experimental, analytical, prospective, longitudinal study in patients with ACL reconstruction in a period from 2016 to 2017. The concentration of IGF-1 in synovial fluid of these patients operated with allograft and autograft was determined, its association with postoperative evolution was determined. For statistical analysis, two-way ANOVA with Mann-Whitney post-hoc U was used. RESULTS: A significant increase in IGF-1 was identified in the allograft group at 90 days of postopertory. In the autograft group, a significant increase in IGF-1 was observed from 30 days of postoperative. The autograft group was found to have significantly higher levels of IGF-1 (3.27 ± 0.09 ng/ml) compared to the allograft group (2.80 ± 0.11 ng/ml; p 0.001) at 90 days after graft placement. DISCUSSION: IGF-1 levels were higher in patients with autologous graft, knee functionality was clinically similar in both groups at 30 and 90 days.

ANTECEDENTES: El tratamiento para la lesión del ligamento cruzado anterior (LCA) es la reconstrucción quirúrgica. Se desconoce si el resultado mejora, pues depende del tipo de injerto empleado. El factor de crecimiento semejante a la insulina tipo 1(IGF-1) es un potente estimulante de matriz extracelular y del crecimiento de condrocitos. MATERIAL Y MÉTODOS: Estudio experimental, analítico, prospectivo, longitudinal en pacientes con reconstrucción del LCA en un período comprendido entre los años 2016 y 2017. Se determinó la concentración de IGF-1 en el líquido sinovial de estos pacientes operados con aloinjerto y autoinjerto además de determinar su asociación con la evolución postoperatoria. Para el análisis estadístico, se utilizó ANOVA de dos vías post hoc con la prueba U de Mann-Whitney. RESULTADOS: Dentro del grupo de aloinjerto, se identificó un aumento significativo de IGF-1 a los 90 días del postoperatorio. En el grupo de autoinjerto, se observó un aumento significativo de IGF-1 desde los 30 días de postoperatorio. Se encontró además que el grupo de autoinjerto presentó niveles significativamente más altos de IGF-1 (3.27 ± 0.09 ng/ml) en comparación con el grupo de aloinjerto (2.80 ± 0.11 ng/ml; p 0.001) a los 90 días después de la colocación del injerto. DISCUSIÓN: Los niveles de IGF-1 fueron más altos en pacientes con injerto autólogo; la funcionalidad de la rodilla fue clínicamente similar en ambos grupos a los 30 y 90 días.

Assessment of mutagenicity in Parthenium hysterophorus L.

The mutagenic potential of a crude extract of Parthenium hysterophorus L. was assessed in the Salmonella/microsome (Ames) assay and the mouse bone marrow micronucleus test. Results in the bacterial mutagenicity assay were negative for the five strains employed, e.g. TA 1535, TA1537, TA 98, TA 100 and TA 102, while cytotoxicity was evident in all cases at 5000 microg per plate, the highest concentration assayed. A decrease in toxicity was observed with exogenous mammalian metabolic activation (S9) or glutathione (5 micromol per plate). When mutagenicity was monitored after column chromatography fractionation of the crude, fraction 1 was mutagenic in strain TA 98 (+S9). Besides, cytotoxicity was found in fraction 5, where parthenin was eluted. The micronucleus test was negative in mice upon oral administration, at doses up to 96 mg of crude per kg. Bone marrow toxicity was not observed. The crude extract exhibited some in vitro pro-oxidant activity. It also inhibited lipid peroxidation (IC(50)=4.1 microg/ml) but failed to act as .OH scavenger.